Carnitine palmitoyltransferase II deficiency, severe infantile form (Q104474): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed an Item
 
(6 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
A forma infantil grave de deficiência de carnitina palmitoiltransferase II, um transtorno hereditário que afeta a oxidação mitocondrial de ácidos graxos de cadeia longa é a forma de início precoce da doença. A apresentação pode ser no período neonatal, mas a maioria dos casos tem início entre 6 e 24 meses. A doença é caracterizada por intolerância ao jejum grave, levando a distúrbios metabólicos caracterizados por hipoglicemia hipocetótica, resultando em coma, convulsões e encefalopatia hepática. Há miopatia do músculo esquelético associada e cardiomiopatia que pode levar a arritmias cardíacas paroxísticas fatais.
description / endescription / en
 
The severe infantile form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the early-onset form of the disease. Presentation can be in the newborn period but most cases have an age of onset between 6 and 24 months. The disease is characterised by a severe fasting intolerance leading to metabolic derangements of hypoketotic hypoglycaemia, resulting in coma and seizures, and hepatic encephalopathy leading to liver failure. There is associated skeletal muscle myopathy and cardiomyopathy which can lead to fatal paroxysmal cardiac arrhythmias.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1488785910 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_1488785910
Property / CURIE: CID11:ID_1488785910 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_1488785910
Property / Canary Token: dki-india-ID_1488785910 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
16 August 2026
Timestamp+2026-08-16T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 16 August 2026 / rank
 
Normal rank

Latest revision as of 10:19, 17 August 2026

The severe infantile form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the early-onset form of the disease. Presentation can be in the newborn period but most cases have an age of onset between 6 and 24 months. The disease is characterised by a severe fasting intolerance leading to metabolic derangements of hypoketotic hypoglycaemia, resulting in coma and seizures, and hepatic encephalopathy leading to liver failure. There is associated skeletal muscle myopathy and cardiomyopathy which can lead to fatal paroxysmal cardiac arrhythmias.
Language Label Description Also known as
default for all languages
ID_1488785910
    English
    Carnitine palmitoyltransferase II deficiency, severe infantile form
    The severe infantile form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the early-onset form of the disease. Presentation can be in the newborn period but most cases have an age of onset between 6 and 24 months. The disease is characterised by a severe fasting intolerance leading to metabolic derangements of hypoketotic hypoglycaemia, resulting in coma and seizures, and hepatic encephalopathy leading to liver failure. There is associated skeletal muscle myopathy and cardiomyopathy which can lead to fatal paroxysmal cardiac arrhythmias.

      Statements

      CID11:ID_1488785910
      0 references
      dki-india-ID_1488785910
      0 references
      Concluído
      0 references
      16 August 2026
      0 references